Papers
15
Total Citations
495
H-Index
10
About
Matthew R. Cooperberg is a leading urologic oncologist and health services researcher whose work has fundamentally shaped the understanding of treatment outcomes in prostate cancer. His research centers on comparative effectiveness, surgical outcomes, and the economics of prostate cancer care, with a particular focus on the real-world performance of robotic versus open radical prostatectomy. Cooperberg’s landmark 2012 cost-utility analysis (127 citations) provided the most comprehensive framework for evaluating the lifetime costs and benefits of primary treatments for localized disease. Through multiple population-based studies, including his 2015 and 2017 papers (64 and 60 citations), he demonstrated that robotic surgery does not consistently offer superior disease control or functional outcomes compared to open surgery, challenging prevailing assumptions. His work on lymphadenectomy adequacy and operative time predictors has refined surgical practice, while his contributions to the EPIC-26 quality-of-life instrument have improved how functional outcomes are interpreted. Cooperberg also leads the Asian Prostate Cancer study, an international initiative to characterize prostate cancer across diverse populations. His research is essential reading for clinicians and researchers seeking evidence-based, patient-centered perspectives on prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy60 citations · 2017
- 4
- 5
- 6Outcomes for Radical Prostatectomy: Is It the Singer, the Song, or Both?36 citations · 2012
- 7
- 8
- 9
- 10Report of the third Asian Prostate Cancer study meeting12 citations · 2018